Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BioSante
BioSante
Why BioSante Expects a Positive Review of Drug for Female Sexual Disorder
Seeking Alpha
Tue, 05/10/11 - 12:05 pm
BioSante
female sexual dysfunction
LibiGel
Is BioSante Giving Away the Store?
Motley Fool
Wed, 04/20/11 - 09:55 am
BioSante
Aduro BioTech
pancreatic cancer
prostate cancer
Analyst ratings boost drug stocks
Marketwatch
Wed, 04/13/11 - 11:08 am
biotech
analysts
Regeneron
GTx
BioSante
FDA to review potential low testosterone treatment developed by BioSante, licensed to Teva
Yahoo/AP
Wed, 04/13/11 - 10:50 am
BioSante
FDA
testosterone
Teva Pharmaceuticals
Bio-T-Gel
BioSante's Potential Blockbuster Treatment
Seeking Alpha
Thu, 03/31/11 - 12:29 pm
BioSante
LibiGel
female sexual dysfunction
Boehringer Ingelheim
Warner Chilcott
BioSante expects to support drug study program with $23.8 million from direct stock offering
Yahoo/AP
Fri, 03/4/11 - 01:00 pm
BioSante
stock offering
Pfizer
BioSante Pharmaceuticals pancreatic cancer drug meets study goals, shares jump
Yahoo/AP
Thu, 03/3/11 - 11:33 am
BioSante
pancreatic cancer
BioSante Pharma completes enrollment in LibiGel phase III efficacy trial
pharmabiz
Sat, 02/26/11 - 11:15 am
BioSante
LibiGel
female sexual dysfunction
BioSante’s Pollyannish Press Release
Forbes
Mon, 02/14/11 - 05:54 pm
BioSante
female sexual dysfunction
LibiGel
BioSante says tests for female sex drug positive
Yahoo/AP
Sun, 02/13/11 - 10:52 am
BioSante
LibiGel
female sexual dysfunction
BioSante rallies on FDA move for melanoma vaccine
Marketwatch
Tue, 01/25/11 - 10:48 am
FDA
BioSante
vaccines
melanoma
BioSante Pharmaceuticals Closes $18 Million Registered Direct Offering to Fund LibiGel® for Female Sexual Dysfunction
Yahoo/BusinessWire
Sun, 01/2/11 - 11:38 am
LibiGel
female sexual dysfunction
BioSante
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
Seeking Alpha
Tue, 12/28/10 - 11:58 am
BioSante
YM BioSciences
Lannett
EnteroMedics
Is BioSante Pharmaceuticals Next in Line to Receive Institutional Praise?
Seeking Alpha
Mon, 12/27/10 - 08:35 am
BioSante
Acadia
Repros Therapeutics
Xoma
BioSante Pharmaceuticals Reports Third Quarter 2010 Financial Results
Centre Daily Times
Sat, 11/13/10 - 01:09 pm
BioSante
earnings
15 Biotech Stocks With the Lowest Put/Call Ratios
Seeking Alpha
Wed, 10/13/10 - 12:09 pm
biotech
Anadys
BioSante
Cerus
CompuGen
Cytokinetics
Cell Therapeutics
Idera Pharmaceuticals
Medivation
MDRA
RXi Pharmaceuticals
Sangamo BioSciences
Talecris
3SBio
Vical
Trimeris
Biosante: Key Catalysts Should Renew Investor Interest
Seeking Alpha
Fri, 10/1/10 - 10:16 am
BioSante
LibiGel
female sexual dysfunction
BioSante Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Sat, 08/14/10 - 12:20 pm
BioSante
investors
Six Trades on FDA, Clinical Trial Binary Events
Seeking Alpha
Tue, 07/13/10 - 09:14 pm
BioSante
LibiGel
testosterone
EntreMed
ENMD-2076
cancer
Protalix BioTherapeutics
UPLYSO
ovarian cancer
Vivus
Qnexa
obesity
EMD 640744
cancer vaccines
Drugmakers Finally Recognize the Next Big Opportunity
Motley Fool
Thu, 06/24/10 - 08:38 am
BioSante
Merck
GSK
Abbott Laboratories
Neurocrine
Teva Pharmaceuticals
women
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »